Northbrook, IL -- (SBWIRE) -- 09/03/2021 -- The Key Growth Elements in Detailed?

The Amniotic Products Market growth is largely driven by factors such as growth in the target patient population, the rising incidence of burn injuries, awareness programs for wound care treatment and management, and the rise in venture capital funding and government investments. The emerging economies and the implementation of the 21st Century Cures Act are expected to provide a wide range of growth opportunities for players in the market. On the other hand, the complications and limitations associated with the use of amniotic membranes are expected to challenge market growth to a certain extent.

Worldwide Growth Opportunities in Terms of Revenue:

The global amniotic products market is projected to reach USD 1,095 million by 2025 from USD 748 million in 2020, at a CAGR of 7.9%.

The amniotic membranes segment is expected to grow at the highest CAGR during the forecast period.

On the basis of type, categorized into two segments, amniotic membranes and amniotic suspensions. The amniotic membranes segment accounted for the largest share of the amniotic products market in 2019. It is also projected to record the highest CAGR during the forecast period. Amniotic membranes have anti-inflammatory, anti-angiogenic, anti-fibrotic, and anti-microbial properties. These benefits of amniotic membranes support their adoption. This is a major factor driving market growth.

Hospitals & ASCs are the largest end users of amniotic products.

Based on end user, segmented into hospitals & ASCs and other end users. In 2019, hospitals & ASCs accounted for the largest share of the amniotic products market. Factors such as the high demand for wound care biologics (including amniotic tissue products) in hospitals and ASCs, the high patient inflow in this care setting, and the availability of reimbursements are driving the growth of this segment.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=191575976

Regional Growth, Development and Demand Analysis:

The global amniotic products market has been divided into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America accounted for the largest share of the global Amniotic Membranes Market in 2019. This can be attributed to the high prevalence of target diseases, increasing geriatric population, rising awareness about advanced treatment options, and the strong presence of key market players of amniotic products. The presence of a well-established healthcare system and ongoing investments by hospitals to upgrade & expand their operating capabilities are other factors supporting market growth in North America.

Major Key Players Mentioned in the research report are:

The prominent players operating in this market include MiMedx (US), Smith & Nephew (UK), Organogenesis (US), and Integra LifeSciences Corporation (US). Other players include Stryker Corporation (US), Wright Medical (Netherlands), Applied Biologics (US), Celularity (US), Katena Products (US), Lucina BioSciences (US), Next Biosciences (South Africa), Skye Biologics (US), Surgenex (US), TissueTech (US), Ventris Medical (US), StimLabs (US), VIVEX Biologics (US), LifeCell International (India), NuVision Biotherapies (England), and Genesis Biologics (US).

Organogenesis (US) is another leading player in the amniotic products market owing to its strong brand recognition and comprehensive suite of amniotic products such as NuCel, NuShield, ReNu, and Affinity. The company has a robust brand presence, serving more than 4,000 healthcare facilities, inclusive of hospital systems, IDNs, and GPOs. The company sells its products to various end users, including hospitals, wound care centers, government facilities, ASCs, and physicians' offices.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=191575976